| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.24B | -52.7% |
| Cost of Revenue | $1.46B | -68.8% |
| R&D Expense | $4.54B | -6.2% |
| SG&A Expense | $1.17B | -24.2% |
| Operating Income | -$3.94B | +6.9% |
| Pre-tax Income | -$3.61B | +8.5% |
| Income Tax | -$46.0M | -106.0% |
| Net Income | -$3.56B | +24.5% |
| EPS (Basic) | -$9.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.93B | -33.7% |
| Accounts Receivable | $358.0M | -59.9% |
| Inventory | $117.0M | -42.1% |
| Current Assets | $8.10B | -21.6% |
| Total Assets | $14.14B | -23.2% |
| Current Liabilities | $2.21B | -26.8% |
| Total Liabilities | $3.24B | -29.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.00B | +3.7% |
| Capital Expenditures | $1.05B | +48.7% |
| Investing Cash Flow | $1.95B | -53.7% |
| Financing Cash Flow | $56.0M | +104.1% |
| Free Cash Flow | -$4.05B | -6.0% |
| +24.7% |
| EPS (Diluted) | -$9.28 | +24.7% |
| Stockholders' Equity |
| $10.90B |
| -21.3% |